Global Self-administered Parenteral Market Insights, Forecast to 2030

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Self-administered Parenteral Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Self-administered Parenteral Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
  • 1.2.2 Pre-filled Syringes
  • 1.2.3 Autoinjectors
  • 1.2.4 Pen Injectors
  • 1.2.5 Others
• 1.3 Market by Application
  • 1.3.1 Global Self-administered Parenteral Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
  • 1.3.2 Pharmacy
  • 1.3.3 Online Sales
  • 1.3.4 Other
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Executive Summary

• 2.1 Global Self-administered Parenteral Sales Estimates and Forecasts 2019-2030
• 2.2 Global Self-administered Parenteral Revenue by Region
  • 2.2.1 Global Self-administered Parenteral Revenue by Region: 2019 VS 2023 VS 2030
  • 2.2.2 Global Self-administered Parenteral Revenue by Region (2019-2024)
  • 2.2.3 Global Self-administered Parenteral Revenue by Region (2025-2030)
  • 2.2.4 Global Self-administered Parenteral Revenue Market Share by Region (2019-2030)
• 2.3 Global Self-administered Parenteral Sales Estimates and Forecasts 2019-2030
• 2.4 Global Self-administered Parenteral Sales by Region
  • 2.4.1 Global Self-administered Parenteral Sales by Region: 2019 VS 2023 VS 2030
  • 2.4.2 Global Self-administered Parenteral Sales by Region (2019-2024)
  • 2.4.3 Global Self-administered Parenteral Sales by Region (2025-2030)
  • 2.4.4 Global Self-administered Parenteral Sales Market Share by Region (2019-2030)
• 2.5 US & Canada
• 2.6 Europe
• 2.7 China
• 2.8 Asia (excluding China)
• 2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

• 3.1 Global Self-administered Parenteral Sales by Manufacturers
  • 3.1.1 Global Self-administered Parenteral Sales by Manufacturers (2019-2024)
  • 3.1.2 Global Self-administered Parenteral Sales Market Share by Manufacturers (2019-2024)
  • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Self-administered Parenteral in 2023
• 3.2 Global Self-administered Parenteral Revenue by Manufacturers
  • 3.2.1 Global Self-administered Parenteral Revenue by Manufacturers (2019-2024)
  • 3.2.2 Global Self-administered Parenteral Revenue Market Share by Manufacturers (2019-2024)
  • 3.2.3 Global Top 10 and Top 5 Companies by Self-administered Parenteral Revenue in 2023
• 3.3 Global Key Players of Self-administered Parenteral, Industry Ranking, 2022 VS 2023 VS 2024
• 3.4 Global Self-administered Parenteral Sales Price by Manufacturers
• 3.5 Analysis of Competitive Landscape
  • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.5.2 Global Self-administered Parenteral Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.6 Global Key Manufacturers of Self-administered Parenteral, Manufacturing Base Distribution and Headquarters
• 3.7 Global Key Manufacturers of Self-administered Parenteral, Product Offered and Application
• 3.8 Global Key Manufacturers of Self-administered Parenteral, Date of Enter into This Industry
• 3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Self-administered Parenteral Sales by Type
  • 4.1.1 Global Self-administered Parenteral Historical Sales by Type (2019-2024)
  • 4.1.2 Global Self-administered Parenteral Forecasted Sales by Type (2025-2030)
  • 4.1.3 Global Self-administered Parenteral Sales Market Share by Type (2019-2030)
• 4.2 Global Self-administered Parenteral Revenue by Type
  • 4.2.1 Global Self-administered Parenteral Historical Revenue by Type (2019-2024)
  • 4.2.2 Global Self-administered Parenteral Forecasted Revenue by Type (2025-2030)
  • 4.2.3 Global Self-administered Parenteral Revenue Market Share by Type (2019-2030)
• 4.3 Global Self-administered Parenteral Price by Type
  • 4.3.1 Global Self-administered Parenteral Price by Type (2019-2024)
  • 4.3.2 Global Self-administered Parenteral Price Forecast by Type (2025-2030)

5 Market Size by Application

• 5.1 Global Self-administered Parenteral Sales by Application
  • 5.1.1 Global Self-administered Parenteral Historical Sales by Application (2019-2024)
  • 5.1.2 Global Self-administered Parenteral Forecasted Sales by Application (2025-2030)
  • 5.1.3 Global Self-administered Parenteral Sales Market Share by Application (2019-2030)
• 5.2 Global Self-administered Parenteral Revenue by Application
  • 5.2.1 Global Self-administered Parenteral Historical Revenue by Application (2019-2024)
  • 5.2.2 Global Self-administered Parenteral Forecasted Revenue by Application (2025-2030)
  • 5.2.3 Global Self-administered Parenteral Revenue Market Share by Application (2019-2030)
• 5.3 Global Self-administered Parenteral Price by Application
  • 5.3.1 Global Self-administered Parenteral Price by Application (2019-2024)
  • 5.3.2 Global Self-administered Parenteral Price Forecast by Application (2025-2030)

6 US & Canada

• 6.1 US & Canada Self-administered Parenteral Market Size by Type
  • 6.1.1 US & Canada Self-administered Parenteral Sales by Type (2019-2030)
  • 6.1.2 US & Canada Self-administered Parenteral Revenue by Type (2019-2030)
• 6.2 US & Canada Self-administered Parenteral Market Size by Application
  • 6.2.1 US & Canada Self-administered Parenteral Sales by Application (2019-2030)
  • 6.2.2 US & Canada Self-administered Parenteral Revenue by Application (2019-2030)
• 6.3 US & Canada Self-administered Parenteral Market Size by Country
  • 6.3.1 US & Canada Self-administered Parenteral Revenue by Country: 2019 VS 2023 VS 2030
  • 6.3.2 US & Canada Self-administered Parenteral Sales by Country (2019-2030)
  • 6.3.3 US & Canada Self-administered Parenteral Revenue by Country (2019-2030)
  • 6.3.4 US
  • 6.3.5 Canada

7 Europe

• 7.1 Europe Self-administered Parenteral Market Size by Type
  • 7.1.1 Europe Self-administered Parenteral Sales by Type (2019-2030)
  • 7.1.2 Europe Self-administered Parenteral Revenue by Type (2019-2030)
• 7.2 Europe Self-administered Parenteral Market Size by Application
  • 7.2.1 Europe Self-administered Parenteral Sales by Application (2019-2030)
  • 7.2.2 Europe Self-administered Parenteral Revenue by Application (2019-2030)
• 7.3 Europe Self-administered Parenteral Market Size by Country
  • 7.3.1 Europe Self-administered Parenteral Revenue by Country: 2019 VS 2023 VS 2030
  • 7.3.2 Europe Self-administered Parenteral Sales by Country (2019-2030)
  • 7.3.3 Europe Self-administered Parenteral Revenue by Country (2019-2030)
  • 7.3.4 Germany
  • 7.3.5 France
  • 7.3.6 U.K.
  • 7.3.7 Italy
  • 7.3.8 Netherlands

8 China

• 8.1 China Self-administered Parenteral Market Size
  • 8.1.1 China Self-administered Parenteral Sales (2019-2030)
  • 8.1.2 China Self-administered Parenteral Revenue (2019-2030)
• 8.2 China Self-administered Parenteral Market Size by Application
  • 8.2.1 China Self-administered Parenteral Sales by Application (2019-2030)
  • 8.2.2 China Self-administered Parenteral Revenue by Application (2019-2030)

9 Asia (excluding China)

• 9.1 Asia Self-administered Parenteral Market Size by Type
  • 9.1.1 Asia Self-administered Parenteral Sales by Type (2019-2030)
  • 9.1.2 Asia Self-administered Parenteral Revenue by Type (2019-2030)
• 9.2 Asia Self-administered Parenteral Market Size by Application
  • 9.2.1 Asia Self-administered Parenteral Sales by Application (2019-2030)
  • 9.2.2 Asia Self-administered Parenteral Revenue by Application (2019-2030)
• 9.3 Asia Self-administered Parenteral Sales by Region
  • 9.3.1 Asia Self-administered Parenteral Revenue by Region: 2019 VS 2023 VS 2030
  • 9.3.2 Asia Self-administered Parenteral Revenue by Region (2019-2030)
  • 9.3.3 Asia Self-administered Parenteral Sales by Region (2019-2030)
  • 9.3.4 Japan
  • 9.3.5 South Korea
  • 9.3.6 China Taiwan
  • 9.3.7 Southeast Asia
  • 9.3.8 India

10 Middle East, Africa and Latin America

• 10.1 Middle East, Africa and Latin America Self-administered Parenteral Market Size by Type
  • 10.1.1 Middle East, Africa and Latin America Self-administered Parenteral Sales by Type (2019-2030)
  • 10.1.2 Middle East, Africa and Latin America Self-administered Parenteral Revenue by Type (2019-2030)
• 10.2 Middle East, Africa and Latin America Self-administered Parenteral Market Size by Application
  • 10.2.1 Middle East, Africa and Latin America Self-administered Parenteral Sales by Application (2019-2030)
  • 10.2.2 Middle East, Africa and Latin America Self-administered Parenteral Revenue by Application (2019-2030)
• 10.3 Middle East, Africa and Latin America Self-administered Parenteral Sales by Country
  • 10.3.1 Middle East, Africa and Latin America Self-administered Parenteral Revenue by Country: 2019 VS 2023 VS 2030
  • 10.3.2 Middle East, Africa and Latin America Self-administered Parenteral Revenue by Country (2019-2030)
  • 10.3.3 Middle East, Africa and Latin America Self-administered Parenteral Sales by Country (2019-2030)
  • 10.3.4 Brazil
  • 10.3.5 Mexico
  • 10.3.6 Turkey
  • 10.3.7 Israel
  • 10.3.8 GCC Countries

11 Company Profiles

• 11.1 Becton, Dickinson and Company
  • 11.1.1 Becton, Dickinson and Company Company Information
  • 11.1.2 Becton, Dickinson and Company Overview
  • 11.1.3 Becton, Dickinson and Company Self-administered Parenteral Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.1.4 Becton, Dickinson and Company Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.1.5 Becton, Dickinson and Company Recent Developments
• 11.2 scPharmaceuticals
  • 11.2.1 scPharmaceuticals Company Information
  • 11.2.2 scPharmaceuticals Overview
  • 11.2.3 scPharmaceuticals Self-administered Parenteral Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.2.4 scPharmaceuticals Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.2.5 scPharmaceuticals Recent Developments
• 11.3 Harro Hofliger
  • 11.3.1 Harro Hofliger Company Information
  • 11.3.2 Harro Hofliger Overview
  • 11.3.3 Harro Hofliger Self-administered Parenteral Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.3.4 Harro Hofliger Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.3.5 Harro Hofliger Recent Developments
• 11.4 Owen Mumford
  • 11.4.1 Owen Mumford Company Information
  • 11.4.2 Owen Mumford Overview
  • 11.4.3 Owen Mumford Self-administered Parenteral Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.4.4 Owen Mumford Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.4.5 Owen Mumford Recent Developments
• 11.5 Haselmeier
  • 11.5.1 Haselmeier Company Information
  • 11.5.2 Haselmeier Overview
  • 11.5.3 Haselmeier Self-administered Parenteral Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.5.4 Haselmeier Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.5.5 Haselmeier Recent Developments
• 11.6 Stevanato Group
  • 11.6.1 Stevanato Group Company Information
  • 11.6.2 Stevanato Group Overview
  • 11.6.3 Stevanato Group Self-administered Parenteral Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.6.4 Stevanato Group Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.6.5 Stevanato Group Recent Developments
• 11.7 Ypsomed AG
  • 11.7.1 Ypsomed AG Company Information
  • 11.7.2 Ypsomed AG Overview
  • 11.7.3 Ypsomed AG Self-administered Parenteral Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.7.4 Ypsomed AG Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.7.5 Ypsomed AG Recent Developments
• 11.8 Solteam Group
  • 11.8.1 Solteam Group Company Information
  • 11.8.2 Solteam Group Overview
  • 11.8.3 Solteam Group Self-administered Parenteral Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.8.4 Solteam Group Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.8.5 Solteam Group Recent Developments
• 11.9 AstraZeneca
  • 11.9.1 AstraZeneca Company Information
  • 11.9.2 AstraZeneca Overview
  • 11.9.3 AstraZeneca Self-administered Parenteral Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.9.4 AstraZeneca Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.9.5 AstraZeneca Recent Developments
• 11.10 Enable lnjections
  • 11.10.1 Enable lnjections Company Information
  • 11.10.2 Enable lnjections Overview
  • 11.10.3 Enable lnjections Self-administered Parenteral Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.10.4 Enable lnjections Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.10.5 Enable lnjections Recent Developments
• 11.11 CCBio
  • 11.11.1 CCBio Company Information
  • 11.11.2 CCBio Overview
  • 11.11.3 CCBio Self-administered Parenteral Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.11.4 CCBio Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.11.5 CCBio Recent Developments
• 11.12 Phillips-Medisize Corporation
  • 11.12.1 Phillips-Medisize Corporation Company Information
  • 11.12.2 Phillips-Medisize Corporation Overview
  • 11.12.3 Phillips-Medisize Corporation Self-administered Parenteral Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.12.4 Phillips-Medisize Corporation Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.12.5 Phillips-Medisize Corporation Recent Developments
• 11.13 Sorrel Medical
  • 11.13.1 Sorrel Medical Company Information
  • 11.13.2 Sorrel Medical Overview
  • 11.13.3 Sorrel Medical Self-administered Parenteral Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.13.4 Sorrel Medical Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.13.5 Sorrel Medical Recent Developments
• 11.14 Krontec Healthcare
  • 11.14.1 Krontec Healthcare Company Information
  • 11.14.2 Krontec Healthcare Overview
  • 11.14.3 Krontec Healthcare Self-administered Parenteral Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.14.4 Krontec Healthcare Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.14.5 Krontec Healthcare Recent Developments
• 11.15 Subcuject Aps
  • 11.15.1 Subcuject Aps Company Information
  • 11.15.2 Subcuject Aps Overview
  • 11.15.3 Subcuject Aps Self-administered Parenteral Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.15.4 Subcuject Aps Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.15.5 Subcuject Aps Recent Developments
• 11.16 Ascendia Pharmaceuticals
  • 11.16.1 Ascendia Pharmaceuticals Company Information
  • 11.16.2 Ascendia Pharmaceuticals Overview
  • 11.16.3 Ascendia Pharmaceuticals Self-administered Parenteral Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.16.4 Ascendia Pharmaceuticals Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.16.5 Ascendia Pharmaceuticals Recent Developments
• 11.17 West Pharmaceutical Services, Inc.
  • 11.17.1 West Pharmaceutical Services, Inc. Company Information
  • 11.17.2 West Pharmaceutical Services, Inc. Overview
  • 11.17.3 West Pharmaceutical Services, Inc. Self-administered Parenteral Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.17.4 West Pharmaceutical Services, Inc. Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.17.5 West Pharmaceutical Services, Inc. Recent Developments

12 Industry Chain and Sales Channels Analysis

• 12.1 Self-administered Parenteral Industry Chain Analysis
• 12.2 Self-administered Parenteral Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Self-administered Parenteral Production Mode & Process
• 12.4 Self-administered Parenteral Sales and Marketing
  • 12.4.1 Self-administered Parenteral Sales Channels
  • 12.4.2 Self-administered Parenteral Distributors
• 12.5 Self-administered Parenteral Customers

13 Market Dynamics

• 13.1 Self-administered Parenteral Industry Trends
• 13.2 Self-administered Parenteral Market Drivers
• 13.3 Self-administered Parenteral Market Challenges
• 13.4 Self-administered Parenteral Market Restraints

14 Key Findings in The Global Self-administered Parenteral Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details
• 15.3 Disclaimer

List of Tables

• Table 1. Global Self-administered Parenteral Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
• Table 2. Major Manufacturers of Pre-filled Syringes
• Table 3. Major Manufacturers of Autoinjectors
• Table 4. Major Manufacturers of Pen Injectors
• Table 5. Major Manufacturers of Others
• Table 6. Global Self-administered Parenteral Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
• Table 7. Global Self-administered Parenteral Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
• Table 8. Global Self-administered Parenteral Revenue by Region (2019-2024) & (US$ Million)
• Table 9. Global Self-administered Parenteral Revenue by Region (2025-2030) & (US$ Million)
• Table 10. Global Self-administered Parenteral Revenue Market Share by Region (2019-2024)
• Table 11. Global Self-administered Parenteral Revenue Market Share by Region (2025-2030)
• Table 12. Global Self-administered Parenteral Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
• Table 13. Global Self-administered Parenteral Sales by Region (2019-2024) & (K Units)
• Table 14. Global Self-administered Parenteral Sales by Region (2025-2030) & (K Units)
• Table 15. Global Self-administered Parenteral Sales Market Share by Region (2019-2024)
• Table 16. Global Self-administered Parenteral Sales Market Share by Region (2025-2030)
• Table 17. Global Self-administered Parenteral Sales by Manufacturers (2019-2024) & (K Units)
• Table 18. Global Self-administered Parenteral Sales Share by Manufacturers (2019-2024)
• Table 19. Global Self-administered Parenteral Revenue by Manufacturers (2019-2024) & (US$ Million)
• Table 20. Global Self-administered Parenteral Revenue Share by Manufacturers (2019-2024)
• Table 21. Global Key Players of Self-administered Parenteral, Industry Ranking, 2022 VS 2023 VS 2024
• Table 22. Self-administered Parenteral Price by Manufacturers 2019-2024 (US$/Unit)
• Table 23. Global Self-administered Parenteral Manufacturers Market Concentration Ratio (CR5 and HHI)
• Table 24. Global Self-administered Parenteral by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Self-administered Parenteral as of 2023)
• Table 25. Global Key Manufacturers of Self-administered Parenteral, Manufacturing Base Distribution and Headquarters
• Table 26. Global Key Manufacturers of Self-administered Parenteral, Product Offered and Application
• Table 27. Global Key Manufacturers of Self-administered Parenteral, Date of Enter into This Industry
• Table 28. Mergers & Acquisitions, Expansion Plans
• Table 29. Global Self-administered Parenteral Sales by Type (2019-2024) & (K Units)
• Table 30. Global Self-administered Parenteral Sales by Type (2025-2030) & (K Units)
• Table 31. Global Self-administered Parenteral Sales Share by Type (2019-2024)
• Table 32. Global Self-administered Parenteral Sales Share by Type (2025-2030)
• Table 33. Global Self-administered Parenteral Revenue by Type (2019-2024) & (US$ Million)
• Table 34. Global Self-administered Parenteral Revenue by Type (2025-2030) & (US$ Million)
• Table 35. Global Self-administered Parenteral Revenue Share by Type (2019-2024)
• Table 36. Global Self-administered Parenteral Revenue Share by Type (2025-2030)
• Table 37. Self-administered Parenteral Price by Type (2019-2024) & (US$/Unit)
• Table 38. Global Self-administered Parenteral Price Forecast by Type (2025-2030) & (US$/Unit)
• Table 39. Global Self-administered Parenteral Sales by Application (2019-2024) & (K Units)
• Table 40. Global Self-administered Parenteral Sales by Application (2025-2030) & (K Units)
• Table 41. Global Self-administered Parenteral Sales Share by Application (2019-2024)
• Table 42. Global Self-administered Parenteral Sales Share by Application (2025-2030)
• Table 43. Global Self-administered Parenteral Revenue by Application (2019-2024) & (US$ Million)
• Table 44. Global Self-administered Parenteral Revenue by Application (2025-2030) & (US$ Million)
• Table 45. Global Self-administered Parenteral Revenue Share by Application (2019-2024)
• Table 46. Global Self-administered Parenteral Revenue Share by Application (2025-2030)
• Table 47. Self-administered Parenteral Price by Application (2019-2024) & (US$/Unit)
• Table 48. Global Self-administered Parenteral Price Forecast by Application (2025-2030) & (US$/Unit)
• Table 49. US & Canada Self-administered Parenteral Sales by Type (2019-2024) & (K Units)
• Table 50. US & Canada Self-administered Parenteral Sales by Type (2025-2030) & (K Units)
• Table 51. US & Canada Self-administered Parenteral Revenue by Type (2019-2024) & (US$ Million)
• Table 52. US & Canada Self-administered Parenteral Revenue by Type (2025-2030) & (US$ Million)
• Table 53. US & Canada Self-administered Parenteral Sales by Application (2019-2024) & (K Units)
• Table 54. US & Canada Self-administered Parenteral Sales by Application (2025-2030) & (K Units)
• Table 55. US & Canada Self-administered Parenteral Revenue by Application (2019-2024) & (US$ Million)
• Table 56. US & Canada Self-administered Parenteral Revenue by Application (2025-2030) & (US$ Million)
• Table 57. US & Canada Self-administered Parenteral Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
• Table 58. US & Canada Self-administered Parenteral Revenue by Country (2019-2024) & (US$ Million)
• Table 59. US & Canada Self-administered Parenteral Revenue by Country (2025-2030) & (US$ Million)
• Table 60. US & Canada Self-administered Parenteral Sales by Country (2019-2024) & (K Units)
• Table 61. US & Canada Self-administered Parenteral Sales by Country (2025-2030) & (K Units)
• Table 62. Europe Self-administered Parenteral Sales by Type (2019-2024) & (K Units)
• Table 63. Europe Self-administered Parenteral Sales by Type (2025-2030) & (K Units)
• Table 64. Europe Self-administered Parenteral Revenue by Type (2019-2024) & (US$ Million)
• Table 65. Europe Self-administered Parenteral Revenue by Type (2025-2030) & (US$ Million)
• Table 66. Europe Self-administered Parenteral Sales by Application (2019-2024) & (K Units)
• Table 67. Europe Self-administered Parenteral Sales by Application (2025-2030) & (K Units)
• Table 68. Europe Self-administered Parenteral Revenue by Application (2019-2024) & (US$ Million)
• Table 69. Europe Self-administered Parenteral Revenue by Application (2025-2030) & (US$ Million)
• Table 70. Europe Self-administered Parenteral Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
• Table 71. Europe Self-administered Parenteral Revenue by Country (2019-2024) & (US$ Million)
• Table 72. Europe Self-administered Parenteral Revenue by Country (2025-2030) & (US$ Million)
• Table 73. Europe Self-administered Parenteral Sales by Country (2019-2024) & (K Units)
• Table 74. Europe Self-administered Parenteral Sales by Country (2025-2030) & (K Units)
• Table 75. China Self-administered Parenteral Sales by Type (2019-2024) & (K Units)
• Table 76. China Self-administered Parenteral Sales by Type (2025-2030) & (K Units)
• Table 77. China Self-administered Parenteral Revenue by Type (2019-2024) & (US$ Million)
• Table 78. China Self-administered Parenteral Revenue by Type (2025-2030) & (US$ Million)
• Table 79. China Self-administered Parenteral Sales by Application (2019-2024) & (K Units)
• Table 80. China Self-administered Parenteral Sales by Application (2025-2030) & (K Units)
• Table 81. China Self-administered Parenteral Revenue by Application (2019-2024) & (US$ Million)
• Table 82. China Self-administered Parenteral Revenue by Application (2025-2030) & (US$ Million)
• Table 83. Asia Self-administered Parenteral Sales by Type (2019-2024) & (K Units)
• Table 84. Asia Self-administered Parenteral Sales by Type (2025-2030) & (K Units)
• Table 85. Asia Self-administered Parenteral Revenue by Type (2019-2024) & (US$ Million)
• Table 86. Asia Self-administered Parenteral Revenue by Type (2025-2030) & (US$ Million)
• Table 87. Asia Self-administered Parenteral Sales by Application (2019-2024) & (K Units)
• Table 88. Asia Self-administered Parenteral Sales by Application (2025-2030) & (K Units)
• Table 89. Asia Self-administered Parenteral Revenue by Application (2019-2024) & (US$ Million)
• Table 90. Asia Self-administered Parenteral Revenue by Application (2025-2030) & (US$ Million)
• Table 91. Asia Self-administered Parenteral Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
• Table 92. Asia Self-administered Parenteral Revenue by Region (2019-2024) & (US$ Million)
• Table 93. Asia Self-administered Parenteral Revenue by Region (2025-2030) & (US$ Million)
• Table 94. Asia Self-administered Parenteral Sales by Region (2019-2024) & (K Units)
• Table 95. Asia Self-administered Parenteral Sales by Region (2025-2030) & (K Units)
• Table 96. Middle East, Africa and Latin America Self-administered Parenteral Sales by Type (2019-2024) & (K Units)
• Table 97. Middle East, Africa and Latin America Self-administered Parenteral Sales by Type (2025-2030) & (K Units)
• Table 98. Middle East, Africa and Latin America Self-administered Parenteral Revenue by Type (2019-2024) & (US$ Million)
• Table 99. Middle East, Africa and Latin America Self-administered Parenteral Revenue by Type (2025-2030) & (US$ Million)
• Table 100. Middle East, Africa and Latin America Self-administered Parenteral Sales by Application (2019-2024) & (K Units)
• Table 101. Middle East, Africa and Latin America Self-administered Parenteral Sales by Application (2025-2030) & (K Units)
• Table 102. Middle East, Africa and Latin America Self-administered Parenteral Revenue by Application (2019-2024) & (US$ Million)
• Table 103. Middle East, Africa and Latin America Self-administered Parenteral Revenue by Application (2025-2030) & (US$ Million)
• Table 104. Middle East, Africa and Latin America Self-administered Parenteral Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
• Table 105. Middle East, Africa and Latin America Self-administered Parenteral Revenue by Country (2019-2024) & (US$ Million)
• Table 106. Middle East, Africa and Latin America Self-administered Parenteral Revenue by Country (2025-2030) & (US$ Million)
• Table 107. Middle East, Africa and Latin America Self-administered Parenteral Sales by Country (2019-2024) & (K Units)
• Table 108. Middle East, Africa and Latin America Self-administered Parenteral Sales by Country (2025-2030) & (K Units)
• Table 109. Becton, Dickinson and Company Company Information
• Table 110. Becton, Dickinson and Company Description and Major Businesses
• Table 111. Becton, Dickinson and Company Self-administered Parenteral Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 112. Becton, Dickinson and Company Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
• Table 113. Becton, Dickinson and Company Recent Developments
• Table 114. scPharmaceuticals Company Information
• Table 115. scPharmaceuticals Description and Major Businesses
• Table 116. scPharmaceuticals Self-administered Parenteral Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 117. scPharmaceuticals Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
• Table 118. scPharmaceuticals Recent Developments
• Table 119. Harro Hofliger Company Information
• Table 120. Harro Hofliger Description and Major Businesses
• Table 121. Harro Hofliger Self-administered Parenteral Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 122. Harro Hofliger Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
• Table 123. Harro Hofliger Recent Developments
• Table 124. Owen Mumford Company Information
• Table 125. Owen Mumford Description and Major Businesses
• Table 126. Owen Mumford Self-administered Parenteral Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 127. Owen Mumford Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
• Table 128. Owen Mumford Recent Developments
• Table 129. Haselmeier Company Information
• Table 130. Haselmeier Description and Major Businesses
• Table 131. Haselmeier Self-administered Parenteral Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 132. Haselmeier Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
• Table 133. Haselmeier Recent Developments
• Table 134. Stevanato Group Company Information
• Table 135. Stevanato Group Description and Major Businesses
• Table 136. Stevanato Group Self-administered Parenteral Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 137. Stevanato Group Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
• Table 138. Stevanato Group Recent Developments
• Table 139. Ypsomed AG Company Information
• Table 140. Ypsomed AG Description and Major Businesses
• Table 141. Ypsomed AG Self-administered Parenteral Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 142. Ypsomed AG Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
• Table 143. Ypsomed AG Recent Developments
• Table 144. Solteam Group Company Information
• Table 145. Solteam Group Description and Major Businesses
• Table 146. Solteam Group Self-administered Parenteral Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 147. Solteam Group Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
• Table 148. Solteam Group Recent Developments
• Table 149. AstraZeneca Company Information
• Table 150. AstraZeneca Description and Major Businesses
• Table 151. AstraZeneca Self-administered Parenteral Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 152. AstraZeneca Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
• Table 153. AstraZeneca Recent Developments
• Table 154. Enable lnjections Company Information
• Table 155. Enable lnjections Description and Major Businesses
• Table 156. Enable lnjections Self-administered Parenteral Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 157. Enable lnjections Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
• Table 158. Enable lnjections Recent Developments
• Table 159. CCBio Company Information
• Table 160. CCBio Description and Major Businesses
• Table 161. CCBio Self-administered Parenteral Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 162. CCBio Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
• Table 163. CCBio Recent Developments
• Table 164. Phillips-Medisize Corporation Company Information
• Table 165. Phillips-Medisize Corporation Description and Major Businesses
• Table 166. Phillips-Medisize Corporation Self-administered Parenteral Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 167. Phillips-Medisize Corporation Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
• Table 168. Phillips-Medisize Corporation Recent Developments
• Table 169. Sorrel Medical Company Information
• Table 170. Sorrel Medical Description and Major Businesses
• Table 171. Sorrel Medical Self-administered Parenteral Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 172. Sorrel Medical Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
• Table 173. Sorrel Medical Recent Developments
• Table 174. Krontec Healthcare Company Information
• Table 175. Krontec Healthcare Description and Major Businesses
• Table 176. Krontec Healthcare Self-administered Parenteral Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 177. Krontec Healthcare Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
• Table 178. Krontec Healthcare Recent Developments
• Table 179. Subcuject Aps Company Information
• Table 180. Subcuject Aps Description and Major Businesses
• Table 181. Subcuject Aps Self-administered Parenteral Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 182. Subcuject Aps Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
• Table 183. Subcuject Aps Recent Developments
• Table 184. Ascendia Pharmaceuticals Company Information
• Table 185. Ascendia Pharmaceuticals Description and Major Businesses
• Table 186. Ascendia Pharmaceuticals Self-administered Parenteral Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 187. Ascendia Pharmaceuticals Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
• Table 188. Ascendia Pharmaceuticals Recent Developments
• Table 189. West Pharmaceutical Services, Inc. Company Information
• Table 190. West Pharmaceutical Services, Inc. Description and Major Businesses
• Table 191. West Pharmaceutical Services, Inc. Self-administered Parenteral Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 192. West Pharmaceutical Services, Inc. Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
• Table 193. West Pharmaceutical Services, Inc. Recent Developments
• Table 194. Key Raw Materials Lists
• Table 195. Raw Materials Key Suppliers Lists
• Table 196. Self-administered Parenteral Distributors List
• Table 197. Self-administered Parenteral Customers List
• Table 198. Self-administered Parenteral Market Trends
• Table 199. Self-administered Parenteral Market Drivers
• Table 200. Self-administered Parenteral Market Challenges
• Table 201. Self-administered Parenteral Market Restraints
• Table 202. Research Programs/Design for This Report
• Table 203. Key Data Information from Secondary Sources
• Table 204. Key Data Information from Primary Sources

List of Figures

• Figure 1. Self-administered Parenteral Product Picture
• Figure 2. Global Self-administered Parenteral Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
• Figure 3. Global Self-administered Parenteral Market Share by Type in 2023 & 2030
• Figure 4. Pre-filled Syringes Product Picture
• Figure 5. Autoinjectors Product Picture
• Figure 6. Pen Injectors Product Picture
• Figure 7. Others Product Picture
• Figure 8. Global Self-administered Parenteral Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
• Figure 9. Global Self-administered Parenteral Market Share by Application in 2023 & 2030
• Figure 10. Pharmacy
• Figure 11. Online Sales
• Figure 12. Other
• Figure 13. Self-administered Parenteral Report Years Considered
• Figure 14. Global Self-administered Parenteral Revenue, (US$ Million), 2019 VS 2023 VS 2030
• Figure 15. Global Self-administered Parenteral Revenue 2019-2030 (US$ Million)
• Figure 16. Global Self-administered Parenteral Revenue Market Share by Region in Percentage: 2023 Versus 2030
• Figure 17. Global Self-administered Parenteral Revenue Market Share by Region (2019-2030)
• Figure 18. Global Self-administered Parenteral Sales 2019-2030 ((K Units)
• Figure 19. Global Self-administered Parenteral Sales Market Share by Region (2019-2030)
• Figure 20. US & Canada Self-administered Parenteral Sales YoY (2019-2030) & (K Units)
• Figure 21. US & Canada Self-administered Parenteral Revenue YoY (2019-2030) & (US$ Million)
• Figure 22. Europe Self-administered Parenteral Sales YoY (2019-2030) & (K Units)
• Figure 23. Europe Self-administered Parenteral Revenue YoY (2019-2030) & (US$ Million)
• Figure 24. China Self-administered Parenteral Sales YoY (2019-2030) & (K Units)
• Figure 25. China Self-administered Parenteral Revenue YoY (2019-2030) & (US$ Million)
• Figure 26. Asia (excluding China) Self-administered Parenteral Sales YoY (2019-2030) & (K Units)
• Figure 27. Asia (excluding China) Self-administered Parenteral Revenue YoY (2019-2030) & (US$ Million)
• Figure 28. Middle East, Africa and Latin America Self-administered Parenteral Sales YoY (2019-2030) & (K Units)
• Figure 29. Middle East, Africa and Latin America Self-administered Parenteral Revenue YoY (2019-2030) & (US$ Million)
• Figure 30. The Self-administered Parenteral Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
• Figure 31. The Top 5 and 10 Largest Manufacturers of Self-administered Parenteral in the World: Market Share by Self-administered Parenteral Revenue in 2023
• Figure 32. Global Self-administered Parenteral Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
• Figure 33. Global Self-administered Parenteral Sales Market Share by Type (2019-2030)
• Figure 34. Global Self-administered Parenteral Revenue Market Share by Type (2019-2030)
• Figure 35. Global Self-administered Parenteral Sales Market Share by Application (2019-2030)
• Figure 36. Global Self-administered Parenteral Revenue Market Share by Application (2019-2030)
• Figure 37. US & Canada Self-administered Parenteral Sales Market Share by Type (2019-2030)
• Figure 38. US & Canada Self-administered Parenteral Revenue Market Share by Type (2019-2030)
• Figure 39. US & Canada Self-administered Parenteral Sales Market Share by Application (2019-2030)
• Figure 40. US & Canada Self-administered Parenteral Revenue Market Share by Application (2019-2030)
• Figure 41. US & Canada Self-administered Parenteral Revenue Share by Country (2019-2030)
• Figure 42. US & Canada Self-administered Parenteral Sales Share by Country (2019-2030)
• Figure 43. U.S. Self-administered Parenteral Revenue (2019-2030) & (US$ Million)
• Figure 44. Canada Self-administered Parenteral Revenue (2019-2030) & (US$ Million)
• Figure 45. Europe Self-administered Parenteral Sales Market Share by Type (2019-2030)
• Figure 46. Europe Self-administered Parenteral Revenue Market Share by Type (2019-2030)
• Figure 47. Europe Self-administered Parenteral Sales Market Share by Application (2019-2030)
• Figure 48. Europe Self-administered Parenteral Revenue Market Share by Application (2019-2030)
• Figure 49. Europe Self-administered Parenteral Revenue Share by Country (2019-2030)
• Figure 50. Europe Self-administered Parenteral Sales Share by Country (2019-2030)
• Figure 51. Germany Self-administered Parenteral Revenue (2019-2030) & (US$ Million)
• Figure 52. France Self-administered Parenteral Revenue (2019-2030) & (US$ Million)
• Figure 53. U.K. Self-administered Parenteral Revenue (2019-2030) & (US$ Million)
• Figure 54. Italy Self-administered Parenteral Revenue (2019-2030) & (US$ Million)
• Figure 55. Netherlands Self-administered Parenteral Revenue (2019-2030) & (US$ Million)
• Figure 56. China Self-administered Parenteral Sales Market Share by Type (2019-2030)
• Figure 57. China Self-administered Parenteral Revenue Market Share by Type (2019-2030)
• Figure 58. China Self-administered Parenteral Sales Market Share by Application (2019-2030)
• Figure 59. China Self-administered Parenteral Revenue Market Share by Application (2019-2030)
• Figure 60. Asia Self-administered Parenteral Sales Market Share by Type (2019-2030)
• Figure 61. Asia Self-administered Parenteral Revenue Market Share by Type (2019-2030)
• Figure 62. Asia Self-administered Parenteral Sales Market Share by Application (2019-2030)
• Figure 63. Asia Self-administered Parenteral Revenue Market Share by Application (2019-2030)
• Figure 64. Asia Self-administered Parenteral Revenue Share by Region (2019-2030)
• Figure 65. Asia Self-administered Parenteral Sales Share by Region (2019-2030)
• Figure 66. Japan Self-administered Parenteral Revenue (2019-2030) & (US$ Million)
• Figure 67. South Korea Self-administered Parenteral Revenue (2019-2030) & (US$ Million)
• Figure 68. China Taiwan Self-administered Parenteral Revenue (2019-2030) & (US$ Million)
• Figure 69. Southeast Asia Self-administered Parenteral Revenue (2019-2030) & (US$ Million)
• Figure 70. India Self-administered Parenteral Revenue (2019-2030) & (US$ Million)
• Figure 71. Middle East, Africa and Latin America Self-administered Parenteral Sales Market Share by Type (2019-2030)
• Figure 72. Middle East, Africa and Latin America Self-administered Parenteral Revenue Market Share by Type (2019-2030)
• Figure 73. Middle East, Africa and Latin America Self-administered Parenteral Sales Market Share by Application (2019-2030)
• Figure 74. Middle East, Africa and Latin America Self-administered Parenteral Revenue Market Share by Application (2019-2030)
• Figure 75. Middle East, Africa and Latin America Self-administered Parenteral Revenue Share by Country (2019-2030)
• Figure 76. Middle East, Africa and Latin America Self-administered Parenteral Sales Share by Country (2019-2030)
• Figure 77. Brazil Self-administered Parenteral Revenue (2019-2030) & (US$ Million)
• Figure 78. Mexico Self-administered Parenteral Revenue (2019-2030) & (US$ Million)
• Figure 79. Turkey Self-administered Parenteral Revenue (2019-2030) & (US$ Million)
• Figure 80. Israel Self-administered Parenteral Revenue (2019-2030) & (US$ Million)
• Figure 81. GCC Countries Self-administered Parenteral Revenue (2019-2030) & (US$ Million)
• Figure 82. Self-administered Parenteral Value Chain
• Figure 83. Self-administered Parenteral Production Process
• Figure 84. Channels of Distribution
• Figure 85. Distributors Profiles
• Figure 86. Bottom-up and Top-down Approaches for This Report
• Figure 87. Data Triangulation
• Figure 88. Key Executives Interviewed